Concentration-dependent metabolism of diazepam in mouse liver

被引:13
作者
StPierre, MV
Pang, KS
机构
[1] UNIV TORONTO,FAC PHARM,TORONTO,ON,CANADA
[2] UNIV TORONTO,FAC MED,DEPT PHARMACOL,TORONTO,ON M5S 2S2,CANADA
来源
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1995年 / 23卷 / 03期
关键词
benzodiazepines; diazepam; C-3-hydroxylation and N-demethylation; N-desmethyldiazepam; nordiazepam; temazepam; oxazepam; tubular flow-model; K-m and V-max; metabolite kinetics; perfused mouse liver; moose liver microsomes; in vitro organ correlation;
D O I
10.1007/BF02354284
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Previous mouse liver studies with diazepam (DZ), N-desmethyldiazepam (NZ), and temazepam (TZ) confirmed that under first-order conditions, DZ formed NZ and TZ in parallel. Oxazepam (OZ) was generated via NZ and not TZ despite that performed NZ and TZ were both capable of forming OZ. In the present studies, the concentration-dependent sequential metabolism of DZ was studied in perfused mouse livers and microsomes, with the aim of distinguishing the relative importance of NZ and TZ as precursors of OZ. In microsomal studies, the K(m)s and V(max)s, corrected for binding to microsomal proteins, were 34 mu M and 3.6 nmole/min per mg and 239 mu M and 18 nmole/min per mg, respectively, for N-demethylation and C-3-hydroxylation of DZ. The K(m)s and V(max)s for N-demethylation and C-3-hydroxylation of TZ and NZ, respectively, to form OZ, were 58 mu M and 2.5 nmole/min per mg and 311 mu M and 2 nmole/min per mg, respectively. The constants suggest that at low DZ concentrations, NZ formation predominates and is a major source of OZ, whereas at higher, DZ concentrations, TZ is the important source of OZ. In livers perfused will DZ at input concentrations of 13 to 35 mu M, the extraction ratio of DZ (E{DZ}) decreased from 0.83 to 0.60. NZ was the major metabolite formed although its appearance was less than proportionate with increasing DZ input concentration. By contrast, the formation of TZ increased disproportionately with increasing DZ concentration, whereas that for OZ decreased and paralleled the behavior of NZ. Computer simulations based on a tubular flow model and the in vitro enzymatic parameters provided a poor in vitro-organ correlation. The E{DZ}, appearance rates of the metabolites, and tire extraction ratio of formed NZ (E{NZ, DZ}) were poorly predicted; TZ was incorrectly identified as the major precursor of OZ. Simulations with optimized parameters improved the correlations and identified NZ as the major contributor of OZ. Saturation of DZ N-demethylation at higher DZ concentrations increased the role of TZ in the formation of OZ. The poor aqueous solubility (limiting the concentration range of substrates used in vitro), avid tissue binding mid the coupling of enzymatic reactions in liver favoring sequential metabolism, are possible explanations for the poor in vitro-organ correlation. This work emphasizes tire complexity of tire hepatic intracellular milieu for drug metabolism and the need for additional modeling efforts to adequately describe metabolite kinetics.
引用
收藏
页码:243 / 266
页数:24
相关论文
共 46 条
[11]   INVITRO AND INVIVO ASSESSMENT OF HEPATIC AND EXTRAHEPATIC METABOLISM OF DIAZEPAM IN THE RAT [J].
IGARI, Y ;
SUGIYAMA, Y ;
SAWADA, Y ;
IGA, T ;
HANANO, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (06) :826-828
[12]  
IGARI Y, 1982, DRUG METAB DISPOS, V10, P676
[13]  
INABA T, 1988, DRUG METAB DISPOS, V16, P605
[14]   CLEARANCE OF DIAZEPAM CAN BE IMPAIRED BY ITS MAJOR METABOLITE DESMETHYLDIAZEPAM [J].
KLOTZ, U ;
REIMANN, I .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (02) :161-163
[15]  
LAIDLER KJ, 1973, CHEM KINETICS ENZYME, P89
[16]   CORRELATION BETWEEN INVITRO AND INVIVO DRUG-METABOLISM RATE - OXIDATION OF ETHOXYBENZAMIDE IN RAT [J].
LIN, JH ;
HAYASHI, M ;
AWAZU, S ;
HANANO, M .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1978, 6 (04) :327-337
[17]   EFFECT OF PHENOBARBITAL ON IN-VITRO METABOLISM OF DIAZEPAM IN SEVERAL ANIMAL SPECIES [J].
MARCUCCI, F ;
FANELLI, R ;
MUSSINI, E ;
GARATTINI, S .
BIOCHEMICAL PHARMACOLOGY, 1970, 19 (05) :1771-+
[18]   FUTHER STUDIES ON SPECIES DIFFERENCE IN DIAZEPAM METABOLISM [J].
MARCUCCI, F ;
FANELLI, R ;
MUSSINI, E ;
GARATTIN.S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1970, 9 (02) :253-&
[19]   METABOLISM AND ANTICONVULSANT ACTIVITY OF DIAZEPAM IN GUINEA-PIGS [J].
MARCUCCI, F ;
GUAITANI, A ;
FANELLI, R ;
MUSSINI, E ;
GARATTINI, S .
BIOCHEMICAL PHARMACOLOGY, 1971, 20 (07) :1711-+
[20]   METABOLISM OF DIAZEPAM BY LIVER MICROSOMAL ENZYMES OF RATS AND MICE [J].
MARCUCCI, F ;
FANELLI, R ;
MUSSINI, E ;
GARATTINI, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1969, 7 (03) :307-+